Search Results - "KROISS, Matthias"
-
1
Update in Adrenocortical Carcinoma
Published in The journal of clinical endocrinology and metabolism (01-12-2013)“…Adrenocortical carcinoma (ACC) is an orphan malignancy that has attracted increasing attention during the last decade. Here we provide an update on advances in…”
Get full text
Journal Article -
2
Personalized Management of Pheochromocytoma and Paraganglioma
Published in Endocrine reviews (01-04-2022)“…Abstract Pheochromocytomas/paragangliomas are characterized by a unique molecular landscape that allows their assignment to clusters based on underlying…”
Get full text
Journal Article -
3
The landscape of chromothripsis across adult cancer types
Published in Nature communications (08-05-2020)“…Chromothripsis is a recently identified mutational phenomenon, by which a presumably single catastrophic event generates extensive genomic rearrangements of…”
Get full text
Journal Article -
4
Combination of Lenvatinib and Pembrolizumab Is an Effective Treatment Option for Anaplastic and Poorly Differentiated Thyroid Carcinoma
Published in Thyroid (New York, N.Y.) (01-07-2021)“…Anaplastic thyroid carcinoma (ATC) and metastatic poorly differentiated thyroid carcinomas (PDTCs) are rare aggressive malignancies with poor overall survival…”
Get more information
Journal Article -
5
Plasma steroid metabolome profiling for the diagnosis of adrenocortical carcinoma
Published in European journal of endocrinology (01-02-2019)“…Objective Current workup for the pre-operative distinction between frequent adrenocortical adenomas (ACAs) and rare but aggressive adrenocortical carcinomas…”
Get full text
Journal Article -
6
A Copeptin-Based Approach in the Diagnosis of Diabetes Insipidus
Published in The New England journal of medicine (02-08-2018)“…This study compared the indirect water-deprivation test with direct detection of plasma copeptin, a precursor of arginine vasopressin, in patients with…”
Get full text
Journal Article -
7
Integrated genomic characterization of adrenocortical carcinoma
Published in Nature genetics (01-06-2014)“…Jérôme Bertherat, Aurélien de Reyniès and colleagues perform integrated genomic analyses of adrenocortical carcinomas. They discover recurrent alterations in…”
Get full text
Journal Article -
8
The role of regulated necrosis in endocrine diseases
Published in Nature reviews. Endocrinology (01-08-2021)“…The death of endocrine cells is involved in type 1 diabetes mellitus, autoimmunity, adrenopause and hypogonadotropism. Insights from research on basic cell…”
Get full text
Journal Article -
9
Major Prognostic Role of Ki67 in Localized Adrenocortical Carcinoma After Complete Resection
Published in The journal of clinical endocrinology and metabolism (01-03-2015)“…Background: Recurrence of adrenocortical carcinoma (ACC) even after complete (R0) resection occurs frequently. Objective: The aim of this study was to identify…”
Get full text
Journal Article -
10
Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: a double-blind, randomised, phase 3 study
Published in The lancet oncology (01-04-2015)“…Summary Background Adrenocortical carcinoma is a rare, aggressive cancer for which few treatment options are available. Linsitinib (OSI-906) is a potent, oral…”
Get full text
Journal Article -
11
Inhibition of Cholesterol Esterification in the Adrenal Gland by ATR101/PD132301–2, A Promising Case of Drug Repurposing
Published in Endocrinology (Philadelphia) (01-05-2016)“…Adrenocortical carcinoma (ACC) is a malignancy that harbors a significant risk of recurrence even after complete resection and has a particularly unfavorable…”
Get full text
Journal Article -
12
SOAT1: A Suitable Target for Therapy in High-Grade Astrocytic Glioma?
Published in International journal of molecular sciences (28-03-2022)“…Targeting molecular alterations as an effective treatment for isocitrate dehydrogenase-wildtype glioblastoma (GBM) patients has not yet been established…”
Get full text
Journal Article -
13
Mitotane Inhibits Sterol-O-Acyl Transferase 1 Triggering Lipid-Mediated Endoplasmic Reticulum Stress and Apoptosis in Adrenocortical Carcinoma Cells
Published in Endocrinology (Philadelphia) (01-11-2015)“…Adrenocortical carcinoma (ACC) is a rare malignancy that harbors a dismal prognosis in advanced stages. Mitotane is approved as an orphan drug for treatment of…”
Get full text
Journal Article -
14
Clinical presentation, treatment and outcome of anaplastic thyroid carcinoma: results of a multicenter study in Germany
Published in European journal of endocrinology (01-12-2016)“…Context Anaplastic thyroid carcinoma (ATC) is an orphan disease and confers a dismal prognosis. Standard treatment is not established. Objective The aim of…”
Get full text
Journal Article -
15
Endocrine side effects of cancer immunotherapy
Published in Deutsche medizinische Wochenschrift (1946) (01-12-2020)“…Immune checkpoint inhibitors (ICI) have become a cornerstone in the treatment of various human malignancies. Immune-related adverse events (irAE) are common…”
Get more information
Journal Article -
16
Analysis of plasma 3-methoxytyramine, normetanephrine and metanephrine by ultraperformance liquid chromatography-tandem mass spectrometry: utility for diagnosis of dopamine-producing metastatic phaeochromocytoma
Published in Annals of clinical biochemistry (01-03-2013)“…Measurements of plasma normetanephrine (NMN) and metanephrine (MN) provide a sensitive test for diagnosis of phaeochromocytomas and paragangliomas (PPGLs), but…”
Get more information
Journal Article -
17
Interplay between glucocorticoids and tumor-infiltrating lymphocytes on the prognosis of adrenocortical carcinoma
Published in Journal for immunotherapy of cancer (01-05-2020)“…Adrenocortical carcinoma (ACC) is a rare endocrine malignancy. Tumor-related glucocorticoid excess is present in ~60% of patients and associated with…”
Get full text
Journal Article -
18
Active steroid hormone synthesis renders adrenocortical cells highly susceptible to type II ferroptosis induction
Published in Cell death & disease (17-03-2020)“…Conditions of impaired adrenal function and tissue destruction, such as in Addison’s disease, and treatment resistance of adrenocortical carcinoma (ACC)…”
Get full text
Journal Article -
19
Gemcitabine-Based Chemotherapy in Adrenocortical Carcinoma: A Multicenter Study of Efficacy and Predictive Factors
Published in The journal of clinical endocrinology and metabolism (01-11-2017)“…Abstract Context Adrenocortical carcinoma (ACC) is rare and confers an unfavorable prognosis in advanced stages. Other than combination chemotherapy with…”
Get full text
Journal Article -
20
Simulation-Based Interpretation of Therapeutically Monitored Cabozantinib Plasma Concentration in Advanced Adrenocortical Carcinoma with Hemodialysis
Published in Therapeutic drug monitoring (01-10-2021)“…Adrenocortical carcinoma is an orphan but aggressive malignancy with limited treatment options. Cabozantinib (CAB), a tyrosine kinase inhibitor, has emerged as…”
Get full text
Journal Article